How do depressed rats respond to psychedelics? New data offer insight into the human experience
Despite tricky regulations, research evaluating the antidepressant potential of psychedelics in humans is mushrooming — and the FDA has already approved a nasal spray concoction of the cat tranquilizer ketamine for patients whose depression persists despite conventional therapy.
But scientists still don’t quite fully understand the antidepressant impact of psychedelics on the brain — are the effects purely biological or psychological? A new study looks into the degree and duration of antidepressant effects induced by these drugs — largely branded by governments as illegal hedonistic compounds with no therapeutic potential — in an animal model.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.